Atlassian Announces Fourth Quarter and Fiscal Year 2017 Results
Jul 27, 2017 20:06 pm UTC| Business
Quarterly revenue of $174.3 million, up 37% year-over-year Quarterly IFRS operating margin of (19%) and non-IFRS operating margin of 14% Quarterly free cash flow of $44.5 million SAN FRANCISCO, July 27, 2017 --...
DMC Global Reports Second Quarter Financial Results
Jul 27, 2017 20:06 pm UTC| Business
Second quarter sales of $47.2 million increased 21% sequentially and 14% from Q2 2016DynaEnergetics and NobelClad segments report sequential sales growth of 22% and 20%, respectivelyGross margin increased to 30% from 27%...
Green Bancorp, Inc. Reports Second Quarter 2017 Financial Results
Jul 27, 2017 20:06 pm UTC| Business
2017 Second Quarter Highlights (GAAP) Second quarter 2017 net income totaled $12.9 million, or $0.35 per diluted common shareReturn (annualized) on average assets was 1.26% for Q2 2017, an increase from 0.73% in Q1...
FNCB Bancorp, Inc. Increases Third Quarter Dividend 50%
Jul 27, 2017 20:06 pm UTC| Business
DUNMORE, Pa., July 27, 2017 -- On July 27, 2017, the Board of Directors of FNCB Bancorp, Inc. (OTCQX:FNCB) declared a dividend of $0.03 per share for the third quarter of 2017, representing a 50.0% increase over the...
VASCO Reports Results for Second Quarter and First Six Months of 2017
Jul 27, 2017 20:06 pm UTC| Business
Q2 Total revenue of $45.7 millionQ2 GAAP operating income (loss) of $(0.4) millionQ2 GAAP earnings per share of $0.00Q2 Non-GAAP earnings per share of $0.071 OAKBROOK TERRACE, Ill. and ZURICH, Switzerland, July 27, 2017...
Integer Holdings Corporation Reports Second Quarter 2017 Results
Jul 27, 2017 20:06 pm UTC| Business
~ Results Reflect Continued Sales Growth; Company Increases Low End of Sales Outlook ~~ Full Year Non-GAAP Adjusted EPS Outlook Updated for Impact of Foreign Currency Losses ~~ Adjusted EPS Outlook from Business Operations...
Versartis Reports Second Quarter 2017 Financial Results
Jul 27, 2017 20:06 pm UTC| Business
MENLO PARK, Calif., July 27, 2017 -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan, a novel, long-acting form of recombinant human growth hormone (rhGH) for...